HOME >> BIOLOGY >> NEWS
Fish Are Better Than Some Drug Treatments For Heart Attack Victims

Diet Containing Oil-Rich Fish Confers More Benefit Than Some Pharmacological Regimens

Click below to download PDF document
You will require Acrobat Reader to view file.
Click here for PDF document

In a letter in this week's BMJ, Roger Harrison from Wigan and Bolton Health Authority and Michael Burr from the University of Wales College of Medicine comment on a study reporting that the benefits of a diet containing oil-rich fish for survivors of heart attack may exceed those from some pharma-cological regimens. In their study of 2033 male survivors of heart attack, deaths were reduced by one third among those who ate oil-rich fish on a regular basis. The authors of the letter point out that this simple and cheap dietary intervention was not found to have any important side effects.

Contact:

Roger Harrison, NHS Research Fellow, Wigan and Bolton Health Authority, Wigan
t:+44 1942 772760
f: +44 1942 772769

email:roger_harrison@yahoo.com


'"/>

Contact: Jill Shepherd
jshepherd@bma.org.uk
44-171-383-6529
BMJ-British Medical Journal
23-Oct-1998


Page: 1

Related biology news :

1. Better living through urban ecology
2. Better techniques needed to predict earthquake hazards, UC study finds
3. Better model of cancer development sheds light on potential angiogenesis target
4. Natural Science and Public Health: Prescription for a Better Environment
5. Better computer modeling provides a new look at large biomolecules
6. UF nutritionist: Better to vow to eat healthy for new year
7. Better "bugs" lead to cheaper ethanol from biomass
8. Diet and cancer prevention: a sampler of story ideas for 5-a-Day for Better Health Week
9. Some Atlantic Coast Beaches Are Shrinking While Floridas Beaches Better Off Than Most
10. New Polyester Products Perform Better And Are Easy To Recycle
11. Better Binding Through Chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: